Gaudium IVF & Women Health lists at 5% premium on the BSE
The scrip is currently trading at Rs. 80.75, up by 1.75 points or 2.22% from its issue price
Gaudium IVF & Women Health has debuted at Rs 83.00 on the BSE, up by 4 points or 5.06% from its issue price of Rs 79.00.
The scrip is currently trading at Rs. 80.75, up by 1.75 points or 2.22% from its issue price.
It has touched a high and low of Rs. 87.15 and Rs. 79.05 respectively. So far 4.19 lakh shares were traded on the counter.
The offering, which was open for subscription between February 20, 2026 and February 24, 2026 was subscribed 7.27 times. The issue price was fixed at Rs 79.00 per share i.e. at upper end of price band of Rs 75-79 apiece.
Gaudium IVF & Women Health is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years. The company’s Main centers (Hubs) are located in major cities to cater potential locations across India.
